Study the effect of natural killer cells in pationts with blood cancer disease from other when the injury-infected corona emerging

Raghad Ridha Kadhem; Hiyam Abdel Ridha Kareem

doi:10.53730/ijhs.v6nS1.7354

Authors

Raghad Ridha Kadhem Department of Biology, College of Education for pure, University of Kerbala, Iraq
Hiyam Abdel Ridha Kareem Department of Biology, College of Education for pure, University of Kerbala, Iraq

Keywords:

blood cancer, COVID-19, Lymphocytes

Abstract

Lymphocytes and subgroups of natural killer cells (CD16 and CD56) play an important role in maintaining the function of the immune system. After infection with COVID-19, the total number of lymphocytes and subgroups changes, indicating a possible association between lymphocyte subgroup change and causative mechanisms. For viral diseases, the study showed a clear decrease in peripheral lymphocytes in patients with coronavirus-19. The reason may be attachment to the virus or indirectly due to immune injuries from inflammatory mediators. It is possible that the secretion of lymphocytes circulating in inflammatory lung tissues also leads to lymphocytopenia. And the viral infection can cause an imbalance in the levels of lymphocyte subgroups, as the cell surface molecules of CD16 and CD56 natural killer cells participate in the humoral and cytotoxic immunity against viral infection, where a decrease in the level of these cells was observed less in severe cases compared to mild cases. Patients with lymphocytic leukemia often suffer from weak immune status When they are exposed to risk factors for contracting COVID-19.

Downloads

Download data is not yet available.

References

Zhou, B., Thao, T. T. N., Hoffmann, D., Taddeo, A., Ebert, N., Labroussaa, F., Pohlmann, A., King, J., Steiner, S., Kelly, J. N., Portmann, J., Halwe, N. J., Ulrich, L., Trüeb, B. S., Fan, X., Hoffmann, B., Wang, L., Thomann, L., Lin, X., … Beer, M. (2021). SARS-CoV-2 spike D614G change enhances replication and transmission. Nature, 592(7852), 122–127. https://doi.org/10.1038/s41586-021-03361-1

Hu, B., Guo, H., Zhou, P., & Shi, Z. L. (2021). Characteristics of SARS-CoV-2 and COVID-19. Nature Reviews Microbiology, 19(3), 141–154. https://doi.org/10.1038/s41579-020-00459-7

Eissens, D. N., Spanholtz, J., van der Meer, A., van Cranenbroek, B., Dolstra, H., Kwekkeboom, J., Preijers, F. W. M. B., & Joosten, I. (2012). Defining early human NK cell developmental stages in primary and secondary lymphoid tissues. PLoS ONE, 7(2). https://doi.org/10.1371/journal.pone.0030930

Wan, S., Yi, Q., Fan, S., Lv, J., Zhang, X., Guo, L., Lang, C., Xiao, Q., Xiao, K., Yi, Z., Qiang, M., Xiang, J., Zhang, B., Chen, Y., & Gao, C. (2020). Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients. British Journal of Haematology, 189(3), 428–437. https://doi.org/10.1111/bjh.16659

Wang, F., Nie, J., Wang, H., Zhao, Q., Xiong, Y., Deng, L., Song, S., Ma, Z., Mo, P., & Zhang, Y. (2020). Characteristics of peripheral lymphocyte subset alteration in covid-19 pneumonia. Journal of Infectious Diseases, 221(11), 1762–1769. https://doi.org/10.1093/INFDIS/JIAA150

Pasin, F., Calveri, M. M., Pizzarelli, G., Calabrese, A., Andreoli, M., Bongiovanni, I., Cattaneo, C., & Rignanese, G. (2020). Oncolytic effect of SARS-CoV2 in a patient with s lymphoma. Acta Biomedica, 91(3), 1–3. https://doi.org/10.23750/abm.v91i3.10141

Büscher, M. (2019). Flow Cytometry Instrumentation – An Overview. Current Protocols in Cytometry, 87(1). https://doi.org/10.1002/cpcy.52

Zola, H., Swart, B., Nicholson, I., Aasted, B., Bensussan, A., Boumsell, L., Buckley, C., Clark, G., Drbal, K., Engel, P., Hart, D., Horejsí, V., Isacke, C., Macardle, P., Malavasi, F., Mason, D., Olive, D., Saalmueller, A., Schlossman, S. F., … Warren, H. (2005). CD molecules 2005: Human cell differentiation molecules. Blood, 106(9), 3123–3126. https://doi.org/10.1182/blood-2005-03-1338

Cooper, M. A., Fehniger, T. A., & Caligiuri, M. A. (2001). The biology of human natural killer-cell subsets. In Trends in Immunology (Vol. 22, Issue 11). https://doi.org/10.1016/S1471-4906(01)02060-9

Van Acker, H. H., Capsomidis, A., Smits, E. L., & Van Tendeloo, V. F. (2017). CD56 in the immune system: More than a marker for cytotoxicity? Frontiers in Immunology, 8(JUL), 1–9. https://doi.org/10.3389/fimmu.2017.00892

Bi, J. (2022). NK cell dysfunction in patients with COVID-19. Cellular and Molecular Immunology, 19(2), 127–129. https://doi.org/10.1038/s41423-021-00825-2

Kalicińska, E., Szymczak, D., Andrasiak, I., Bogucka-Fedorczuk, A., Zińczuk, A., Szymański, W., Biernat, M., Rymko, M., Semeńczuk, G., Jabłonowska, P., Rybka, J., Simon, K., & Wróbel, T. (2021). Lymphocyte subsets in haematological patients with COVID-19: Multicentre prospective study. Translational Oncology, 14(1). https://doi.org/10.1016/j.tranon.2020.100943

Chu, H., Zhou, J., Wong, B. H. Y., Li, C., Chan, J. F. W., Cheng, Z. S., Yang, D., Wang, D., Lee, A. C. Y., Li, C., Yeung, M. L., Cai, J. P., Chan, I. H. Y., Ho, W. K., To, K. K. W., Zheng, B. J., Yao, Y., Qin, C., & Yuen, K. Y. (2016). Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways. Journal of Infectious Diseases, 213(6). https://doi.org/10.1093/infdis/jiv380

Ragab, D., Salah Eldin, H., Taeimah, M., Khattab, R., & Salem, R. (2020). The COVID-19 Cytokine Storm; What We Know So Far. Frontiers in Immunology, 11(June), 1–4. https://doi.org/10.3389/fimmu.2020.01446

Tan, L., Wang, Q., Zhang, D., Ding, J., Huang, Q., Tang, Y. Q., Wang, Q., & Miao, H. (2020). Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduction and Targeted Therapy, 5(1), 16–18. https://doi.org/10.1038/s41392-020-0148-4